The approval of QUVIVIQ™, a novel dual orexin receptor antagonist, is based on robust clinical efficacy and safety data, including…
HCAA's flagship event to provide visionary leadership and industry insights for executive leadership at third-party administrators (TPAs), brokers, and benefit…
CALIFORNIA CITY, CA / ACCESSWIRE / September 23, 2024 / Perfidy has just released a range of new natural help…
The Institute's Collaborative Model with the Center for Incubation & Findings Research (CIFR) and Compassion Center Sets the Stage for…
MISSISSAUGA, ON / ACCESSWIRE / September 23, 2024 / Science & Humans (S&H), Canada's leading platform for hormone health, is…
Jackson Memorial Health System Philips MX550 IntelliVue Portable Bedside Patient Monitor with Shield Philips MX750, MX850, IntelliVue, Patient Monitors with…
Strong improvement in State-Trait Anger Expression Inventory 2 (STAXI-2) Trait Anger, a measure of agitation and aggression, at Weeks 8–12…
New certification program features generative and conversational AI developed in-house, setting a new standard in healthcare training Program's AI-based characters…
As a leader in neuroscience, Teva is committed to researching new treatment innovations that may help address unmet needs in…
As a leader in neuroscience, Teva remains committed to helping address unmet needs in the treatment of schizophrenia through scientific…